SCHEMBL14136259

SCHEMBL14136259

CC(=O)N1N=C(c2ccc(NS(=O)(=O)c3ccc(Cl)cc3)cc2)CC1c1ccc(N(C)C)cc1

nearest known ligand 0.67

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 6/20 0.67
▸ NPC1 O15118 2/20 0.61
▸ RAB9A P51151 2/20 0.61
▸ KDM4E B2RXH2 1/20 0.61
▸ SMN1; SMN2 Q16637 1/20 0.61
▸ MAOA P21397 1/20 0.60
▸ MAOB P27338 1/20 0.60
▸ CA12 O43570 2/20 0.58
▸ CA1 P00915 2/20 0.58
▸ CA2 P00918 2/20 0.58
▸ CA9 Q16790 2/20 0.58
▸ MEN1 O00255 1/20 0.57
▸ KMT2A Q03164 1/20 0.57
▸ EGFR P00533 2/20 0.56
▸ ALDH1A1 P00352 1/20 0.56
▸ TDP1 Q9NUW8 1/20 0.56
▸ TERT O14746 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14136252 0.93 PTGS2 (0.77) PTGS2NPC1RAB9AMAOAMAOB
SCHEMBL14133489 0.91 KDM4E (0.64) PTGS2NPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL14136239 0.90 PTGS2 (0.71) PTGS2NPC1RAB9AKDM4EMAOA
SCHEMBL14058064 0.89 PTGS2 (0.70) PTGS2NPC1RAB9AMAOAMAOB
SCHEMBL14133910 0.89 PTGS2 (0.69) PTGS2NPC1RAB9AMAOAMAOB
SCHEMBL14136236 0.89 PTGS2 (0.69) PTGS2NPC1RAB9AKDM4EMAOA
SCHEMBL14058025 0.87 NPC1 (0.78) PTGS2NPC1RAB9AMAOAMAOB
SCHEMBL14133795 0.86 KDM4E (0.80) PTGS2NPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL14136234 0.84 PTGS2 (0.76) PTGS2KDM4EMAOAMAOBCA12
SCHEMBL14146846 0.84 ALDH1A1 (0.57) PTGS2NPC1RAB9AKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012160447-A1 3, 5 -DIPHENYL- SUBSTITUTED PYRAZOLINES FOR THE TREATMENT OF CANCER, PROLIFERATIVE, INFLAMMATORY OR AUTOIMMUNE DISEASES DYNAMIX PHARMACEUTICALS LTD. (IL) 2012-11-29 — — WO disclosed
Send feedback